Greek-based ProGnosis Biotech is a leading biotech firm, developing innovative in-vitro tests for diverse sectors. With exports to 62+ countries, we focus on accurate, user-friendly immunological tests, maintaining GMP and ISO standards. Our ISO 9001:2015 and ISO 13485:2016 affirm our quality commitment. Specializing in lateral flow devices, we offer full-service design to production, surpassing client expectations and rigorous regulatory standards.